Benitec Biopharma (BNTC) Change in Cash (2019 - 2025)
Benitec Biopharma (BNTC) posted Change in Cash of $94.3 million for Q4 2025, up 2988.55% sequentially from -$3.3 million in Q3 2025, and up 803.36% YoY from $10.4 million in Q4 2024.
Benitec Biopharma (BNTC) Change in Cash (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported Change in Cash for 7 years, with the latest figure at $94.3 million in Q4 2025.
- Quarterly Change in Cash rose 803.36% year-over-year to $94.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $110.6 million (up 90.76% YoY) and the FY2025 annual result came in at $46.9 million, down 3.12% from the prior year.
- Change in Cash advanced to $94.3 million in Q4 2025 per BNTC's latest filing, from -$3.3 million in the prior quarter.
- Over five years, Change in Cash peaked at $94.3 million in Q4 2025 and troughed at -$6.2 million in Q1 2024.
- A 5-year average of $8.7 million and a median of -$3.3 million in 2021 frame the typical range for Change in Cash.
- The sharpest annual moves came in 2022 and 2024: Change in Cash tumbled 158.72% in 2022, then soared 1002.4% in 2024.
- Over 5 years, Change in Cash stood at -$3.4 million in 2021, then plunged by 76.46% to -$6.0 million in 2022, then climbed by 8.46% to -$5.5 million in 2023, then surged by 290.2% to $10.4 million in 2024, then soared by 803.36% to $94.3 million in 2025.
- According to Business Quant data, Change in Cash over the past three periods registered $94.3 million, -$3.3 million, and -$5.8 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 649.20 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -504.60 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 374.50 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 427.25 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -1.97 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 225.59 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -2.94 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -37.42 Mn |
| 10 | Benitec Biopharma | 577.39 Mn | 388.49 Mn | - | 94.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 94.31 Mn |
| Sep 30, 2025 | -3.27 Mn |
| Jun 30, 2025 | -5.79 Mn |
| Mar 31, 2025 | 25.30 Mn |
| Dec 31, 2024 | 10.44 Mn |
| Sep 30, 2024 | 16.98 Mn |
| Jun 30, 2024 | 36.77 Mn |
| Mar 31, 2024 | -6.23 Mn |
| Dec 31, 2023 | -5.49 Mn |
| Sep 30, 2023 | 23.39 Mn |
| Jun 30, 2023 | -4.08 Mn |
| Mar 31, 2023 | -3.99 Mn |
| Dec 31, 2022 | -6.00 Mn |
| Sep 30, 2022 | 12.47 Mn |
| Jun 30, 2022 | -4.57 Mn |
| Mar 31, 2022 | -3.70 Mn |
| Dec 31, 2021 | -3.40 Mn |
| Sep 30, 2021 | -4.04 Mn |
| Jun 30, 2021 | 7.78 Mn |
| Mar 31, 2021 | -2.02 Mn |